As a member of the SREBP isoforms primarily implicated in hepatic FA synthesis, SREBP-1c activates the transcription of ACC1, FAS, and SCD1, thereby stimulating the DNL pathway and leading to the production of substantial quantities of FA, resulting in hepatic steatosis (Choi et al., 2014). Here, SREBF1 is linked to fatty liver disease.